| Pharmaceuticals Industry | Healthcare Sector | Mr. Hong-Gul Cheong CEO | KRX SM Exchange | - ISIN |
| KR Country | 59 Employees | - Last Dividend | 26 May 2021 Last Split | - IPO Date |
ADBiotech Co., Ltd., founded in 2000 and based in Chuncheon-si, South Korea, operates within the biotechnology sector, focusing on the development and sale of antibodies. The company has established itself in both local and international markets, providing a wide range of biotechnological products aimed at improving health in livestock, fishes, and humans. ADBiotech's strategic location and its broad range of products reflect its commitment to leveraging biotechnology for better health outcomes across different species.